Fluconazole-Niosome-Laden Contact Lens: A Promising Therapeutic Approach for Prolonged Ocular Delivery and Enhanced Antifungal Activity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Fluconazole-Niosome-Laden Contact Lens: A Promising Therapeutic Approach for Prolonged Ocular Delivery and Enhanced Antifungal Activity ; volume:19 ; number:4 ; day:20 ; month:7 ; year:2024 ; pages:1-15 ; date:8.2024
Journal of pharmaceutical innovation ; 19, Heft 4 (20.7.2024), 1-15, 8.2024
- Creator
-
Yassin, Ghada E.
Amer, Mai A.
Mannaa, Islam M.
Khalifa, Maha Khalifa Ahmed
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12247-024-09850-w
- URN
-
urn:nbn:de:101:1-2411212224132.135274143747
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yassin, Ghada E.
- Amer, Mai A.
- Mannaa, Islam M.
- Khalifa, Maha Khalifa Ahmed
- SpringerLink (Online service)
Other Objects (12)
Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy
Hydrogel Containing PEG-Coated Fluconazole Nanoparticles with Enhanced Solubility and Antifungal Activity
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Factors predicting prolonged empirical antifungal treatment in critically ill patients
Development of antifungal fibrous ocular insert using freeze-drying technique
A new formulation of graphene oxide/fluconazole compound as a promising agent against Candida albicans
K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species
Cyclodextrin–polysaccharide-based, in situ-gelled system for ocular antifungal delivery
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier
Host defence peptides identified in human apolipoprotein B as promising antifungal agents
Microsponges: a promising frontier for prolonged release-current perspectives and patents
Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy
Hydrogel Containing PEG-Coated Fluconazole Nanoparticles with Enhanced Solubility and Antifungal Activity
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Factors predicting prolonged empirical antifungal treatment in critically ill patients
Development of antifungal fibrous ocular insert using freeze-drying technique
A new formulation of graphene oxide/fluconazole compound as a promising agent against Candida albicans
K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species
Cyclodextrin–polysaccharide-based, in situ-gelled system for ocular antifungal delivery
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier
Host defence peptides identified in human apolipoprotein B as promising antifungal agents
Microsponges: a promising frontier for prolonged release-current perspectives and patents
Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy
Hydrogel Containing PEG-Coated Fluconazole Nanoparticles with Enhanced Solubility and Antifungal Activity
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Factors predicting prolonged empirical antifungal treatment in critically ill patients
Development of antifungal fibrous ocular insert using freeze-drying technique
A new formulation of graphene oxide/fluconazole compound as a promising agent against Candida albicans
K21 Compound, a Potent Antifungal Agent: Implications for the Treatment of Fluconazole-Resistant HIV-Associated Candida Species
Cyclodextrin–polysaccharide-based, in situ-gelled system for ocular antifungal delivery
Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier
Host defence peptides identified in human apolipoprotein B as promising antifungal agents